Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC

Introduction: Gene fusion testing of ALK, ROS1, RET, NTRK, and MET exon 14 skipping mutations is guideline recommended in nonsquamous NSCLC (NS-NSCLC). Nevertheless, assessment is often hindered by the limited availability of tissue and prolonged next-generation sequencing (NGS) testing, which can p...

Full description

Bibliographic Details
Main Authors: Véronique Hofman, MD, PhD, Simon Heeke, PhD, Christophe Bontoux, MD, Lara Chalabreysse, MD, Marc Barritault, MD, PhD, Pierre Paul Bringuier, DVM, Tanguy Fenouil, MD, PhD, Nazim Benzerdjeb, MD, PhD, Hugues Begueret, MD, PhD, Jean Philippe Merlio, MD, PhD, Charline Caumont, MD, Nicolas Piton, MD, PhD, Jean-Christophe Sabourin, MD, PhD, Solène Evrard, MD, PhD, Charlotte Syrykh, MD, Anna Vigier, MD, Pierre Brousset, MD, PhD, Julien Mazieres, MD, PhD, Elodie Long-Mira, MD, PhD, Jonathan Benzaquen, MD, PhD, Jacques Boutros, MD, Maryline Allegra, PhD, Virginie Tanga, MSc, Virginie Lespinet-Fabre, PhD, Myriam Salah, MSc, Christelle Bonnetaud, MSc, Olivier Bordone, MSc, Sandra Lassalle, MD, PhD, Charles-Hugo Marquette, MD, PhD, Marius Ilié, MD, PhD, Paul Hofman, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:JTO Clinical and Research Reports
Subjects:
Gene fusion
Non–small cell lung carcinoma
Next generation sequencing
RT-PCR
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322001813

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322001813

Similar Items